73. Patient 2 continued to feel uncomfortable for the remainder of the day. (Test.
Patient 2, T. at 335.)

74. Soon afterward, Patient 2 received a routine e-mail from the Respondent, which
, acknowledged her visit with him on August 18, 2014. (Test. Patient 2, T. at 339; State’s Ex. 42 at
00045.) . .

75. On September 3,:2014, Patient 2 sent an e-mail to the Respondent. In her e-mail,
Patient 2 explained to the Respondent that she believed that the prednisone that he had
prescribed was causing her to develop a rash that had affected her entire body. She wanted him
to prescribe a medication to her to treat the rash, (Test. Patient 2, T. at 340; State’s Ex. 42 at
00021.) .

76. The Respondent did not answer Patient 2’s e-mail concerning her presumed
prednisone-induced rash. (Test. Patient 2, T. at 340.) °

77. On September 3, 2014, Patient 2 sent a second e-mail to the Respondent. In that e-
mail, Patient 2 wanted to know some more about her spinal problems based on the x-ray studies
he performed of her spine on August 18, 2014. (Test. Patient 2, T. at 341.)

78. The Respondent replied to Patient 2’s second September 3, 2014 e-mail, but did
not answer her questions. (Test. Patient 2, T. at 342; State’s Ex. 42 at 00031.) .

79. On October 3, 2014, at 11:29 a.m., Patient 2 sent another e-mail to the
Respondent as a follow-up to her September 3, 2014 e-mail. The Respondent did not reply.
(Test. Patient 2, T. at 342-43.)

80. On October 15, 204 R.N., sent a return e-mail to Patient 2, in
answer to Patient 2’s October 3, 2014 e-mail, indicating that she would forward Patient 2’s

message to the Respondent. (Test. Patient 2, T. at 342-43; State’s Ex. 42 at 00031.)
